Long-Zi Liu
Overview
Explore the profile of Long-Zi Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
415
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang Z, Gao Q, Shi J, Guo W, Yang L, Liu X, et al.
Hepatology
. 2025 Feb;
PMID: 39964298
No abstract available.
2.
Liu L, Zhang Z, Zheng B, Shi Y, Duan M, Ma L, et al.
Hepatology
. 2025 Feb;
81(3):E113-E114.
PMID: 39960205
No abstract available.
3.
Ma L, Feng F, Dong L, Zhang Z, Duan M, Liu L, et al.
Theranostics
. 2018 Dec;
8(20):5690-5702.
PMID: 30555574
The remarkable clinical activity of PD-1 antibody in advanced hepatocellular carcinoma (HCC) highlights the importance of PD-1/PD-L1-mediated immune escape as therapeutic target in HCC. However, the frequency and prognostic significance...
4.
Zheng B, Liu L, Zhang Z, Shi J, Dong L, Tian L, et al.
BMC Cancer
. 2018 Nov;
18(1):1148.
PMID: 30463529
Background: Radiomics is an emerging field in oncological research. In this study, we aimed at developing a radiomics score (rad-score) to estimate postoperative recurrence and survival in patients with solitary...
5.
Liu L, Zhang Z, Zheng B, Shi Y, Duan M, Ma L, et al.
Hepatology
. 2018 Aug;
69(1):143-159.
PMID: 30070719
Chemokines play a key role in orchestrating the recruitment and positioning of myeloid cells within the tumor microenvironment. However, the tropism regulation and functions of these cells in hepatocellular carcinoma...
6.
Dong L, Shi Y, Ma L, Yang L, Wang X, Zhang S, et al.
J Hepatol
. 2018 Mar;
69(1):89-98.
PMID: 29551704
Background & Aims: Intrahepatic cholangiocarcinoma (ICC) is the second-most lethal primary liver cancer. Little is known about intratumoral heterogeneity (ITH) and its impact on ICC progression. We aimed to investigate...
7.
Liu L, Yang L, Zheng B, Dong P, Liu X, Wang Z, et al.
J Surg Oncol
. 2018 Mar;
117(7):1531-1539.
PMID: 29513894
Background And Objectives: Frequently aberrant expression of cytokeratin 7 (CK7) and cytokeratin 19 (CK19) have been observed in several human cancers. In this retrospective study, we aimed at investigating the...
8.
Ma L, Wang X, Duan M, Liu L, Shi J, Dong L, et al.
J Pathol
. 2017 Aug;
243(4):407-417.
PMID: 28833123
The role of telomere dysfunction and aberrant telomerase activities in hepatocellular carcinoma (HCC) has been overlooked for many years. This study aimed to delineate the variation and prognostic value of...
9.
Liu L, He Y, Dong P, Ma L, Wang Z, Liu X, et al.
Oncotarget
. 2016 Sep;
7(46):75210-75220.
PMID: 27655691
The protein tyrosine phosphatase PTP4A1 is a key molecule that activates tyrosine phosphorylation, which is important for cancer progression and metastasis. However, the clinical implications and biological function of PTP4A1...
10.
Gao Q, Wang Z, Duan M, Lin Y, Zhou X, Worthley D, et al.
Gastroenterology
. 2016 Sep;
152(1):232-242.e4.
PMID: 27639803
Background & Aims: No targeted therapies have been found to be effective against hepatocellular carcinoma (HCC), possibly due to the large degree of intratumor heterogeneity. We performed genetic analyses of...